Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Meiji Seika Pharma

    Client Virtual Booth

    MEIJI SEIKA PHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Meiji Seika Pharma
    japan Flag
    Country
    Country
    Japan
    Address
    Address
    4-16, Kyobashi 2-chome, Chuo-ku, Tokyo 104-800
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.meiji.com/global/worldwide-locations.html
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    Meiji Seika to supply Japan with self-amplifying mRNA Covid-19 vaccine
    Meiji Seika to supply Japan with self-amplifying mRNA Covid-19 vaccine

    https://endpts.com/meiji-seika-pharma-to-supply-japan-with-self-amplifying-mrna-covid-19-vaccine-in-fall-winter-of-2024/

    ENDPTS
    22 Mar 2024
    Share Share
    Meiji Seika Pharma Presents Positive Findings from Phase II Study of ME3183
    Meiji Seika Pharma Presents Positive Findings from Phase II Study of ME3183

    https://www.businesswire.com/news/home/20231012881091/en

    BUSINESSWIRE
    13 Oct 2023
    Share Share
    Adcock Ingram Completes Construction of a New Manufacturing Facility in India
    Adcock Ingram Completes Construction of a New Manufacturing Facility in India

    https://www.businesswire.com/news/home/20230530005041/en

    BUSINESSWIRE
    31 May 2023
    Share Share
    Meiji Seika Pharma, Adcock Complete Construction of New Manufacturing Facility
    Meiji Seika Pharma, Adcock Complete Construction of New Manufacturing Facility

    https://www.contractpharma.com/contents/view_breaking-news/2023-05-31/meiji-seika-pharma-adcock-ingram-pharma-complete-construction-of-new-manufacturing-facility/?widget=listSection

    CONTRACT PHARMA
    31 May 2023
    Share Share
    A novel anti-PD-1 agonist antibody discovered through research between Meiji and the Foundation for Biomedical Research and Innovation at Kobe
    A novel anti-PD-1 agonist antibody discovered through research between Meiji and the Foundation for Biomedical Research and Innovation at Kobe

    https://www.businesswire.com/news/home/20230115005001/en

    BUSINESSWIRE
    16 Jan 2023
    Share Share
    Zhejiang Hengkang Meiji Pharma to enter the field of green synthetic biology
    Zhejiang Hengkang Meiji Pharma to enter the field of green synthetic biology

    https://www.hengkangpharm.cn/new_detail/id/17.html

    PRESS RELEASE
    10 Jan 2023
    Share Share
    Meiji Seika Pharma commences Phase III mRNA Covid-19 vaccine trial in Japan
    Meiji Seika Pharma commences Phase III mRNA Covid-19 vaccine trial in Japan

    https://www.clinicaltrialsarena.com/news/meiji-covid-vaccine-trial/

    CLINICALTRIALSARENA
    14 Dec 2022
    Share Share
    First Patient Dosed in Phase II Study of ME3183 in Plaque Psoriasis
    First Patient Dosed in Phase II Study of ME3183 in Plaque Psoriasis

    https://www.businesswire.com/news/home/20220406005042/en

    BUSINESSWIRE
    07 Apr 2022
    Share Share
    Meiji Completed Phase I Studies and Moves Onto Phase II Study of ME3183
    Meiji Completed Phase I Studies and Moves Onto Phase II Study of ME3183

    https://www.businesswire.com/news/home/20210823005696/en

    BUSINESSWIRE
    24 Aug 2021
    Share Share
    Meiji Seika Pharma: Promising Results of Phase I Clinical Trial of DMB-3115
    Meiji Seika Pharma: Promising Results of Phase I Clinical Trial of DMB-3115

    https://www.biospace.com/article/releases/meiji-seika-pharma-promising-results-of-phase-i-clinical-trial-of-dmb-3115-a-proposed-ustekinumab-biosimilar-and-initiation-of-phase-iii-clinical-trial-in-patients-with-plaque-psoriasis/

    BIOSPACE
    21 May 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search